Home LiteratureArticle Details
PMID: 8306080 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Pharmacological characterization of the metabotropic glutamate receptor inhibiting D-[3H]-aspartate output in rat striatum.

British journal of pharmacology ·Vol. 110 ·No. 4 ·1993-12-00 ·Pages 1407-12

Lombardi G, Alesiani M, Leonardi P, Cherici G, Pellicciari R, Moroni F

Abstract

1. The effects of several agonists of the metabotropic glutamate receptor (mGluR) were studied in adult rat striatal slices by measuring (i) KCl (30 mM)-induced output of previously taken up D-[3H]-aspartate (Asp), (ii) forskolin (30 microM)-induced adenosine 3':5'-cyclic monophosphate (cyclic AMP) accumulation and (iii) phophoinositide (PI) hydrolysis. 2. K(+)-induced efflux of D-[3H]-Asp was inhibited by the following mGluR agonists: (1S,3S,4S)-(carboxycyclopropyl)glycine (L-CCG-I), (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) and quisqualic acid (Quis). 2-Amino-4-phosphonobutyrate (L-AP4) was inactive up to 300 microM. The maximal inhibition of D-[3H]-Asp output was 60 +/- 8%. The EC50s of mGluR agonists were: 0.5 microM for L-CCG-I, 100 microM for 1S,3R-ACPD and 100 microM for Quis. 3. Forskolin-induced cyclic AMP accumulation was also inhibited by mGluR agonists. The maximal inhibition was 50 +/- 4% and was obtained at a concentration of 10 microM for L-CCG-I and 100 microM for 1S,3R-ACPD. The EC50s for this inhibition were: 0.9 microM for L-CCG-I and 20 microM for 1S,3R-ACPD. Quis (300 microM) inhibited cyclic AMP accumulation by approximately 20%. L-AP4 slightly potentiated cyclic AMP accumulation. 4. PI hydrolysis was stimulated by mGluR agonists. The most potent compound was Quis (100 microM), which increased inositol phosphate formation up to 2.2 fold over control values. Its EC50 was 15 microM. L-CCG-I and 1S,3R-ACPD increased inositol phosphate formation by approximately 1.8 fold and their EC50 values were 30 and 25 microM, respectively. L-AP4 did not affect PI hydrolysis. 5. In conclusion, mGluR agonists that reduce D-[3H]-Asp output have a pharmacological profile similar to that of mGluR agonists inhibiting cyclic AMP accumulation. L-CCG-I appears to be a relatively selective agonist for the mGluR receptor which inhibits D-[3H]-Asp efflux and cyclic AMP accumulation,while Quis appears to act preferentially on the mGluR receptor linked to the metabolism of PIs.

MeSH Terms
Amino Acids, Dicarboxylic/pharmacology Animals Aspartic Acid/metabolism Colforsin/pharmacology Corpus Striatum/metabolism Cyclic AMP/metabolism Cycloleucine/analogs & derivatives,pharmacology In Vitro Techniques Male Phosphatidylinositols/metabolism Quisqualic Acid/pharmacology Rats Rats, Wistar Receptors, Glutamate/drug effects
Chemicals
Amino Acids, Dicarboxylic Phosphatidylinositols Receptors, Glutamate Cycloleucine 1-amino-1,3-dicarboxycyclopentane Colforsin (alpha-carboxycyclopropyl)glycine Aspartic Acid Quisqualic Acid Cyclic AMP
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Lombardi G
Dipartimento di Farmacologia Preclinica e Clinica Mario Aiazzi Mancini, Università di Firenze, Italy.
Alesiani M
Leonardi P
Cherici G
Pellicciari R
Moroni F
References (59)
59 references, click to expand
  1. Noradrenaline inhibition of acetylcholine release from guinea-pig brain.
    Eur J Pharmacol. 1978 Mar 15;48(2):179-93 PMID: 639848
  2. Trans-1-aminocyclopentane-1,3-dicarboxylic acid (t-ACPD) decreases synaptic excitation in rat striatal slices through a presynaptic action.
    Neurosci Lett. 1991 Aug 5;129(1):17-21 PMID: 1656337
  3. Cortical lesions modulate turnover rates of acetylcholine and gamma-aminobutyric acid.
    Neurosci Lett. 1979 May;12(2-3):349-54 PMID: 460733
  4. The release of gamma-aminobutyric acid, glutamate, and acetylcholine from striatal slices: a mass fragmentographic study.
    J Neurochem. 1981 May;36(5):1691-9 PMID: 6113268
  5. Glutamate-preferring receptors regulate the release of D-[3H]aspartate from rat hippocampal slices.
    Nature. 1981 Jun 18;291(5816):593-4 PMID: 6264312
  6. Micromolar L-2-amino-4-phosphonobutyric acid selectively inhibits perforant path synapses from lateral entorhinal cortex.
    Brain Res. 1981 Jul 6;216(1):192-8 PMID: 6266585
  7. Presynaptic regulation of the release of catecholamines.
    Pharmacol Rev. 1980 Dec;32(4):337-62 PMID: 6267618
  8. Characterization of the binding of DL-[3H]-2-amino-4-phosphonobutyrate to L-glutamate-sensitive sites on rat brain synaptic membranes.
    Br J Pharmacol. 1983 Oct;80(2):355-64 PMID: 6140060
  9. Kainic acid evoked release of D-[3H]aspartate from rat striatum in vitro: characterization and pharmacological modulation.
    Can J Physiol Pharmacol. 1984 Sep;62(9):1070-7 PMID: 6498619
  10. Inositol trisphosphate, a novel second messenger in cellular signal transduction.
    Nature. 1984 Nov 22-28;312(5992):315-21 PMID: 6095092
  11. Release of D-[3H]aspartic acid from the rat striatum. Effect of veratridine-evoked depolarization, fronto-parietal cortex ablation, and striatal lesions with kainic acid.
    Biochem Pharmacol. 1985 Apr 15;34(8):1217-24 PMID: 2581579
  12. Presynaptic alpha-autoreceptors.
    Rev Physiol Biochem Pharmacol. 1987;107:73-146 PMID: 2887026
  13. Morphine withdrawal in vitro: potentiation of agonist-dependent polyphosphoinositide breakdown.
    Eur J Pharmacol. 1988 May 10;149(3):297-306 PMID: 2842165
  14. Sodium dependent 3H-noradrenaline release from rat neocortical slices in the absence of extracellular calcium: presynaptic modulation by mu-opioid receptor and adenylate cyclase activation.
    Naunyn Schmiedebergs Arch Pharmacol. 1988 Nov;338(5):548-52 PMID: 2854212
  15. L(+)-2-amino-4-phosphonobutyrate inhibits the release of both glutamate and dynorphin from guinea pig but not rat hippocampal mossy fiber synaptosomes.
    Brain Res. 1989 Aug 21;495(1):151-5 PMID: 2570625
  16. Inhibition of excitatory amino acid-stimulated phosphoinositide hydrolysis in the neonatal rat hippocampus by 2-amino-3-phosphonopropionate.
    J Neurochem. 1989 Dec;53(6):1865-70 PMID: 2572680
  17. Potent NMDA-like actions and potentiation of glutamate responses by conformational variants of a glutamate analogue in the rat spinal cord.
    Br J Pharmacol. 1989 Dec;98(4):1213-24 PMID: 2692753
  18. Arachidonic acid released from striatal neurons by joint stimulation of ionotropic and metabotropic quisqualate receptors.
    Nature. 1990 Sep 13;347(6289):182-4 PMID: 1975645
  19. Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission.
    Cerebrovasc Brain Metab Rev. 1990 Spring;2(1):27-57 PMID: 2169834
  20. (2S,3S,4S) alpha-(carboxycyclopropyl)glycine is a novel agonist of metabotropic glutamate receptors.
    Eur J Pharmacol. 1990 Aug 2;184(1):205-6 PMID: 1976529
  21. Presynaptic glutamate receptors depress excitatory monosynaptic transmission between mouse hippocampal neurones.
    J Physiol. 1990 Oct;429:1-16 PMID: 2177502
  22. Sequence and expression of a metabotropic glutamate receptor.
    Nature. 1991 Feb 28;349(6312):760-5 PMID: 1847995
  23. A potent metabotropic glutamate receptor agonist: electrophysiological actions of a conformationally restricted glutamate analogue in the rat spinal cord and Xenopus oocytes.
    Brain Res. 1990 Dec 24;537(1-2):311-4 PMID: 1964837
  24. Trans-ACPD depresses synaptic transmission in the hippocampus.
    Eur J Pharmacol. 1991 Jan 25;193(1):131-2 PMID: 1646727
  25. Enhanced sensitivity of "metabotropic" glutamate receptors after induction of long-term potentiation in rat hippocampus.
    J Neurochem. 1991 Aug;57(2):376-83 PMID: 1649248
  26. The bioenergetics of neurotransmitter release.
    Biochim Biophys Acta. 1991 Sep 13;1059(3):243-64 PMID: 1680396
  27. The role of the metabotropic receptor in synaptic plasticity.
    Trends Pharmacol Sci. 1991 Sep;12(9):324-6 PMID: 1659000
  28. A family of metabotropic glutamate receptors.
    Neuron. 1992 Jan;8(1):169-79 PMID: 1309649
  29. Inhibition of cyclic AMP formation by a selective metabotropic glutamate receptor agonist.
    J Neurochem. 1992 Mar;58(3):1184-6 PMID: 1310724
  30. Inhibition of forskolin-stimulated cyclic AMP formation by 1-aminocyclopentane-trans-1,3-dicarboxylate in guinea-pig cerebral cortical slices.
    J Neurochem. 1992 May;58(5):1964-6 PMID: 1313857
  31. Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluR1, in transfected CHO cells.
    Neuron. 1992 Apr;8(4):757-65 PMID: 1314623
  32. A significant increase in intracellular Ca2+ concentration induced by (2S,3R,4S)-2-(carboxycyclopropyl)glycine, a new potent NMDA agonist, in cultured rat hippocampal neurons.
    Brain Res. 1991 Dec 20;567(2):342-5 PMID: 1840131
  33. L-AP4 inhibits calcium currents and synaptic transmission via a G-protein-coupled glutamate receptor.
    J Neurosci. 1992 Jun;12(6):2043-50 PMID: 1318954
  34. Inhibition of the phospholipase C-linked metabotropic glutamate receptor by 2-amino-3-phosphonopropionate is dependent on extracellular calcium.
    J Neurochem. 1992 Aug;59(2):772-5 PMID: 1321236
  35. Metabotropic glutamate receptors are required for the induction of long-term potentiation.
    Neuron. 1992 Jul;9(1):163-72 PMID: 1352982
  36. Developmental changes in the modulation of cyclic AMP formation by the metabotropic glutamate receptor agonist 1S,3R-aminocyclopentane-1,3-dicarboxylic acid in brain slices.
    J Neurochem. 1992 Sep;59(3):1161-3 PMID: 1322971
  37. Trans-ACPD inhibits cAMP formation via a pertussis toxin-sensitive G-protein.
    Eur J Pharmacol. 1992 Apr 10;225(4):357-8 PMID: 1323480
  38. Activation of glutamate metabotropic receptors induces long-term potentiation.
    Eur J Pharmacol. 1992 Apr 22;214(2-3):297-8 PMID: 1325361
  39. Activation of metabotropic receptors has a neuroprotective effect in a rodent model of focal ischaemia.
    Eur J Pharmacol. 1992 Jun 5;216(2):335-6 PMID: 1397020
  40. Activation of the glutamate metabotropic receptor protects retina against N-methyl-D-aspartate toxicity.
    Eur J Pharmacol. 1992 Aug 14;219(1):173-4 PMID: 1397046
  41. Cloning, expression, and gene structure of a G protein-coupled glutamate receptor from rat brain.
    Science. 1991 May 31;252(5010):1318-21 PMID: 1656524
  42. Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures.
    Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9431-5 PMID: 1658782
  43. Activation of quisqualate metabotropic receptors reduces glutamate and GABA-mediated synaptic potentials in the rat striatum.
    Neurosci Lett. 1992 May 11;139(1):41-4 PMID: 1357603
  44. Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage.
    Neurosci Lett. 1992 May 11;139(1):77-82 PMID: 1407685
  45. Trans-ACPD and L-APB presynaptically inhibit excitatory glutamatergic transmission in the basolateral amygdala (BLA).
    Neurosci Lett. 1992 May 11;139(1):87-91 PMID: 1357607
  46. Molecular diversity of glutamate receptors and implications for brain function.
    Science. 1992 Oct 23;258(5082):597-603 PMID: 1329206
  47. Agonist analysis of 2-(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells.
    Br J Pharmacol. 1992 Oct;107(2):539-43 PMID: 1330184
  48. Neurotransmission. A retrograde step forward.
    Nature. 1992 Nov 12;360(6400):106-7 PMID: 1359424
  49. Positive feedback of glutamate exocytosis by metabotropic presynaptic receptor stimulation.
    Nature. 1992 Nov 12;360(6400):163-6 PMID: 1359425
  50. L-aspartate-beta-hydroxamate exhibits mixed agonist/antagonist activity at the glutamate metabotropic receptor in rat neonatal cerebrocortial slices.
    Neurosci Lett. 1992 Sep 14;144(1-2):87-9 PMID: 1436717
  51. L-2-amino-4-phosphonobutyrate (L-AP4) is an agonist at the type IV metabotropic glutamate receptor which is negatively coupled to adenylate cyclase.
    Eur J Pharmacol. 1992 Nov 2;227(3):361-2 PMID: 1361913
  52. 3,5-Dihydroxyphenyl-glycine: a potent agonist of metabotropic glutamate receptors.
    Neuroreport. 1992 Nov;3(11):1013-6 PMID: 1362358
  53. Competitive antagonism at metabotropic glutamate receptors by (S)-4-carboxyphenylglycine and (RS)-alpha-methyl-4-carboxyphenylglycine.
    Eur J Pharmacol. 1993 Jan 15;244(2):195-7 PMID: 8381746
  54. Metabotropic glutamate receptors in brain function and pathology.
    Trends Pharmacol Sci. 1993 Jan;14(1):13-20 PMID: 7680175
  55. Phenylglycine derivatives as new pharmacological tools for investigating the role of metabotropic glutamate receptors in the central nervous system.
    Neuroscience. 1993 Feb;52(3):481-8 PMID: 7680790
  56. Signal transduction, pharmacological properties, and expression patterns of two rat metabotropic glutamate receptors, mGluR3 and mGluR4.
    J Neurosci. 1993 Apr;13(4):1372-8 PMID: 8463825
  57. Subtypes of metabotropic excitatory amino acid receptor distinguished by stereoisomers of the rigid glutamate analogue, 1-aminocyclopentane-1,3-dicarboxylate.
    Neurosci Lett. 1993 Apr 16;153(1):107-10 PMID: 8390029
  58. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  59. Effects of tetrodotoxin, calcium and magnesium on the release of amino acids from slices of guinea-pig cerebral cortex.
    J Neurochem. 1978 Jul;31(1):187-95 PMID: 671016
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
1993-12-00
Pages
1407-12
Language
English
Region
England
NLM ID
7502536
PMCID
PMC2175867
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com